FDA Investigator Lucila B Nwatu

Lucila B Nwatu has conducted inspections on 60 sites in 6 countries as of 25 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
60
Last Inspection Date:
25 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100004914
Countries of Inspections:
United States of America, Korea (Republic of), India, France, Italy, Germany
FDA Investigators that have inspected at least one site in common with Lucila B Nwatu:
Abby E Pelletier, Alan P Kurtzberg, Alex G Kalugin, Alexis R Ajello, Alice A Blair, Alice S Tsao, Alicia M Mozzachio, Alla Dubrovsky, Amir Alavi, Anastasia I Onuorah, Anastasia M Shields, Andrei Perlloni, Andrew E Kay, Andrew K Haack, PhD, Andrew T Todd, Angel K Sandhu, Angela D Wise, Anh M Lac, Anita Narula, PhD, Ann L Demarco, Anna L Marroquin, Anna L Viveros Hernandez, Arsen Karapetyan, Ashar P Parikh, Avery J Dennis, Benny Y Gong, Bo Chi, PhD, Carl Lee, Carolyn A Renshaw, Carrie A Hughes, Caryn M Mcnab, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Celeste K Wong, Charles L Zhou, Chengjiu Hu, Chloe Anne Leong, Christopher J Lee, Christopher R Czajka, Claire M Minden, Courtney R Bolton, Cynthia Jim, CSO, Damon A Growl, Daniel J Roberts, Darlene B Almogela, Darren S Brown, David A Lum, David G Eng, Deborah Schmiel, PhD, Debra D Devlieger, Debra I Love, Dennis Cantellops Paite, Devaughn Edwards, Diane L Raccasi, Dogbeda F Mackenzie, Dr. Barbara D Paul, PhD, Dr. Monica D Cooper, Dr. Ralph M Bernstein, PhD, Dustin P Tran, Dustin R Abaonza, Eileen A Liu, Elisabeth A Drevet, Elizabeth Juarez, Emal Wahab, Eric C Nielsen, Eric L Dong, BS, Erica R Pomeroy, Estefania Fernandez, Felix Maldonado, Frank P Bianco, Gabrielle J Swain, George J Flynn, Glen E Harelson, Guerlain Ulysse, Gunneet Kaur, Gwyn G Dickinson, Helen J Hamaoka, Henry K Lau, Humberto Z Gomez, Hyung Yul Lee, Ingrid A Zambrana, Ismael Garibay, Jacek Cieslak, PhD, James A Lane, James C Lee, PharmD, James R Birkenstamm, James R Evans, Janice R Small, Janice Wai, Jeanmaire Hryshko, Jeanne J Thai, Jeannie Pradyanata, Jeffrey M Watson, Jeffrey P Raimondi, Jeffrey W Shrifter, DPM, Jennifer L Degroot, Jennifer L Johnson, Jenny K Yee, Jessica B Darneille, Joan T Briones, John A Gonzalez, John A Liu, Jolanna A Norton, Jolene S Hedgecock, Jose Acruz Gonzalez, Joseph A Seitz, III, Joseph Kutze, PhD, Joseph M Willems, Juan A Morales, Juanita P Versace, Jude C Dikes, Justin A Boyd, Kacie M Crowther, Karen D Phung, Karla J Gibler, Katherine Szestypalow, Kathryn E King, Keith O Webber, PhD, Keith Webber, PhD, Kendra A Biddick, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kouros Kangarli, Kristin M Abaonza, Lance Mde Souza, MBA, Larkin R Buckalew, Larry K Austin, Laurel A Beer, Laurie Graham, LCDR Jennifer H Rhyu, Linan Ha, PhD, Linda F Murphy, Linda Linh N Adams, Linda Thai, Lydia S Chan, Lynda L Perry, PhD, Macropolk, Madushini Dharmasena, PhD, Maida Henesian (NMI), Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Maridali Deleon Torres, Marion Michaelis, Marissa J Chan, Mariza M Jafary, Mark E Baldwin, Mark E Chan, Mark I Nakano, Marshalette O Edwards, Mary C Acton, Mary R Hole, Matthew A Walburger, Matthew B Casale, Matthew R Clabeaux, Megan E Kulas, Mei Chiung Huang (Jo), Melody M Ragasa Leong, Michael A Charles, Michael D Kawalek, Michael O Skidmore, Michael Shanks, MS, Michele L Obert, Michelle L Lopez, Michelle L Tripp, Michelle Rfrazier Jessen, PhD, Miguel A Martinez Perez, Mihaly S Ligmond, Milos Dokmanovic, PhD, Monica Markovski, PhD, Mra Munizn, Nancy E Boocker, Narong Chamkasem, PhD, Natalia Pripuzova, PhD, Nayan J Patel, Neil J Bonzagni, PhD MPH, Nicholas L Hunt, Nicole Yuen, Nympha V Florendo, Omotunde O Osunsanmi, Paraluman S Leonin, Patricia F Hughes, PhD, Patrick J Lynch, Paula A Trost, Peter E Baker, Phillip Angart, PhD, Phung, Prabhu P Raju, Qing Joanna Zhou, PhD, Rajiv R Srivastava, Ramon A Hernandez, Randall J Plunkett, Randy L Elsberry, Raphael E Brykman, Ravi S Harapanhalli, Raymond T Oji, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richmond K Yip, Riley C Graham, Riley C Myers, PhD, Rita K Kabaso, Rita K Vick, Robert D Tollefsen, Roger D Gawne, Roger F Zabinski, Rumany C Penn, PharmD, Ruth Moore, PhD, Samina S Khan, Sandra A Hughes, Sandra S Saniga, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sarah Arden, Sarah Kennett, PhD, Scott N Lim, Scott T Ballard, Sharon K Thoma, PharmD, Sidney B Priesmeyer, Siobhan A Gallagher, Stephanie A Slater, MS, Stephen D Brown, Steven A Gonzales, Steven B Chiu, Steven Fong, MS, PhD, Steven M Galvez, Steven P Donald, Stuart W Russell, Taichun Qin, PhD, Terrance P Nguyen, Terrence Gee, Terry A Hook, DPh, Thea C Grome, Thomas J Arista, Thomas N Adjabeng, Thomas W Gordon, Thuy T Nguyen, LCDR, Tiffany Chao, Timothy T Kapsala, Tonia F Bernard, Torrance J Slayton, Travelle D Mason, Tristian E Strait, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vaishali J Patel, Vebina K Sethi, Vibhakar J Shah, PhD, Victoria Taylor, Vilmary Negron Rodriguez, Virginia Carroll, PhD, Walden H Lee, Wayne D Mcgrath, Wayne E Seifert, Wayne L Jefferson, William J Weis, William V Millar, Yasamin Ameri, Yong Hu, Yumi J Hiramine, Yun Wu, PhD, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD

Lucila B Nwatu's Documents

Publish Date Document Type Title
June, 2016 FDA 483 Intas Pharmaceuticals Limited - Form 483, 2016-06-17
May, 2015 FDA 483 Response Impax Laboratories, LLC. - Form 483R, 2015-06-01
July, 2022 FDA 483 INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - Form 483, 2022-07-01
December, 2015 EIR CSBio Co. - EIR, 2015-12-07
February, 2018 EIR ALZA Corporation - EIR, 2018-02-01
June, 2016 EIR Intas Pharmaceuticals Limited - EIR, 2017-06-06
May, 2015 FDA 483 Impax Laboratories, LLC. - Form 483, 2015-05-08
June, 2018 FDA 483 Hanmi Fine Chemical Co., Ltd. - Form 483, 2018-06-15
January, 2015 FDA 483 AnazaoHealth Corporation - Form 483, 2015-01-30
February, 2017 FDA 483 Nordmark Pharma GmbH - Form 483, 2017-02-17
February, 2018 FDA 483 ALZA Corporation - Form 483, 2018-02-01
July, 2015 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2015-07-17
September, 2016 EIR Actelion Pharmaceuticals U.S., Inc. - EIR, 2016-09-21
September, 2017 FDA 483 COSMECCA KOREA CO., LTD - Form 483, 2017-09-22
February, 2019 EIR SOFIE Co. dba SOFIE - EIR, 2019-02-05
May, 2017 EIR CSBio Co. - EIR, 2017-05-12
December, 2015 FDA 483 CSBio Co. - Form 483, 2015-12-07
June, 2016 FDA 483 Amneal Oncology Private Limited - Form 483, 2016-06-08
May, 2018 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2018-05-25
May, 2016 EIR Impax Laboratories, LLC. - EIR, 2016-05-04
December, 2015 FDA 483 Acorn NMR Inc. - Form 483, 2015-12-11
May, 2016 FDA 483 Impax Laboratories, LLC. - Form 483, 2016-05-04
February, 2019 FDA 483 RPK Pharmaceuticals, Inc. - Form 483, 2019-02-28
May, 2016 FDA 483 Response Impax Laboratories, LLC. - Form 483R, 2016-05-25
March, 2019 FDA 483 K & D Laboratories, Inc. dba Purity Laboratories, Inc. - Form 483, 2019-03-15
March, 2016 FDA 483 Reliable Rexall-A Compounding Pharmacy - Form 483, 2016-04-20
September, 2016 FDA 483 Actelion Pharmaceuticals U.S., Inc. - Form 483, 2016-09-21
March, 2015 FDA 483 Columbia Cosmetics Manufacturing, Inc. - Form 483, 2015-03-27
May, 2015 EIR Impax Laboratories, LLC. - EIR, 2015-05-08
August, 2016 FDA 483 Raptor Pharmaceuticals Inc. - Form 483, 2016-08-24
June, 2018 FDA 483 Samsung Biologics Co., Ltd. - Form 483, 2018-06-26
May, 2017 FDA 483 CSBio Co. - Form 483, 2017-05-12
March, 2018 FDA 483 One Way Drug DBA Partell Specialty Pharmacy - Form 483, 2018-03-08
August, 2018 FDA 483 Genentech, Inc. - Form 483, 2018-08-22
November, 2016 FDA 483 Assertio Therapeutics, Inc. - Form 483, 2016-11-02
November, 2017 FDA 483 Response Intersect ENT, INC. - Form 483R, 2017-11-28
November, 2017 FDA 483 Intersect ENT, INC. - Form 483, 2017-11-03
December, 2016 FDA 483 Barclay, Luke, & Pillai Specialty Pharmacy, PLLC - Form 483, 2016-12-20
February, 2019 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2019-02-05
July, 2024 FDA 483 BSO LLC - Form 483, 2024-07-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more